Blood test strategy could save money and improve IBD care
NCT ID NCT02508012
First seen Sep 30, 2025 · Last updated Jun 09, 2026 · Updated 35 times
Summary
This study looked at whether regularly measuring the amount of anti-TNF medication and related antibodies in the blood can help doctors make better treatment decisions for people with Crohn's disease or ulcerative colitis. About 260 patients were split into two groups: one where doctors used these blood test results to adjust treatment, and one where they did not. The goal was to see if this monitoring approach improves quality of life and is cost-effective over two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University hospital
Montpellier, 34295, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.